Scarica l'app Stockscreener
6.10
3.39%
0.20
Dopo l'orario di chiusura:
6.27
0.17
+2.79%
Precedente Chiudi:
$5.90
Aprire:
$5.9
Volume 24 ore:
2.44M
Relative Volume:
1.61
Capitalizzazione di mercato:
$638.54M
Reddito:
$69.65M
Utile/perdita netta:
$-81.27M
Rapporto P/E:
-6.7121
EPS:
-0.9088
Flusso di cassa netto:
$-79.45M
1 W Prestazione:
-9.36%
1M Prestazione:
-21.59%
6M Prestazione:
-36.98%
1 anno Prestazione:
+59.27%
Intervallo 1D:
$5.86
$6.18
Intervallo di 1 settimana:
$5.688
$6.603
Portata 52W:
$3.62
$11.50
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
6.10 | 617.60M | 69.65M | -81.27M | -79.45M | -0.9088 |
TMO
Thermo Fisher Scientific Inc
|
469.71 | 173.44B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.25 | 126.39B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
565.93 | 44.55B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.55 | 32.34B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
309.87 | 30.55B | 3.17B | 642.63M | 516.49M | 10.77 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
Personalis (PSNL) Eps Diluted (TTM) - Zacks Investment Research
Personalis to Announce First Quarter 2026 Financial Results - Business Wire
Multiple Insiders Sold Personalis Shares Presenting Weak Signs For Investors - 富途牛牛
Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026 - BioSpace
InvestingPro’s Fair Value predicted 40% drop in Personalis stock By Investing.com - Investing.com
Personalis presents ctDNA monitoring data at cancer research meeting - Investing.com
Needham Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Personalis (NASDAQ:PSNL) Shares Up 6.8%What's Next? - MarketBeat
Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026 - BioSpace
Earnings Beat: Can Personalis Inc deliver consistent EPS growth2026 Pullbacks & Technical Pattern Alert System - baoquankhu1.vn
Breakouts Watch: What is Personalis Incs revenue forecastPortfolio Update Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Trade Recap: Is Personalis Inc benefiting from interest rate changesWeekly Gains Summary & Entry Point Strategy Guides - baoquankhu1.vn
T. Rowe Price lists 4.5% stake in Personalalis (NASDAQ: PSNL) - Stock Titan
Can Personalis Inc stock double in the next yearMarket Weekly Review & Weekly Top Gainers Trade List - baoquankhu1.vn
Market Rankings: Can Personalis Inc stock double in the next yearTrade Performance Summary & Daily Price Action Insights - baoquankhu1.vn
Personalis, Inc. $PSNL Shares Acquired by Aberdeen Group plc - MarketBeat
Is Personalis (PSNL) Stock Risky Now | Price at $6.61, Up 0.46%Shared Momentum Picks - Xã Châu Thành
Personalis, Inc. (NASDAQ:PSNL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Whale Trades: Whats the beta of Personalis Inc stock2026 Market Sentiment & Weekly High Momentum Picks - baoquankhu1.vn
PSNL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PSNL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PSNL Stock Analysis: Personalis Inc. Modest Daily Uptick At 6.58 USD Amid Genomics Sector Trends - Cổng thông tin điện tử tỉnh Lào Cai
Executive pay, board elections headline Personalis (PSNL) 2026 proxy - Stock Titan
Personalis, Inc. (PSNL) stock price, news, quote and history - Yahoo Finance Singapore
Personalis to Participate in the 25th Annual Needham Virtual Conference - ChartMill
PSNL Stock Analysis: Personalis Inc. gains 4.24 pct, holds 6.64 dollar level - Cổng thông tin điện tử tỉnh Tây Ninh
Operating cash flow per share of Personalis, Inc. – DUS:04X - TradingView
Personalis Surges 12% Pre-Market with No Clear Catalyst - Bitget
Morgan Stanley lowers Personalis (PSNL) price target to $10 - MSN
Dow Update: Is Personalis Inc benefiting from interest rate changesMarket Volume Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Personalis (NASDAQ:PSNL) Trading Down 9.3%Should You Sell? - MarketBeat
Personalis stock rises after Medicare approves lung cancer test coverage - Investing.com
Sell Signal: Can Personalis Inc deliver consistent EPS growthOil Prices & Weekly Setup with High ROI Potential - baoquankhu1.vn
Morgan Stanley Lowers Personalis (PSNL) Price Target to $10 - Insider Monkey
10 best diagnostics and research stocks to buy according to analysts - msn.com
Should you avoid Personalis Inc stock right now2026 Trade Ideas & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
PSNL SEC FilingsPersonalis 10-K, 10-Q, 8-K Forms - Stock Titan
Personalis, Inc. (PSNL): A bull case theory - MSN
Personalis appoints Richard Chen as president and updates compensation package - au.investing.com
229,435 Shares in Personalis, Inc. $PSNL Bought by Oracle Investment Management Inc. - MarketBeat
Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption - BioSpace
Personalis promotes Richard Chen to president role By Investing.com - Investing.com South Africa
Personalis appoints Richard Chen as president and updates compensation package By Investing.com - Investing.com India
Personalis (PSNL) Appoints Richard Chen as President - GuruFocus
Personalis (PSNL) CFO granted 206,250 options and 34,375 RSUs - Stock Titan
Personalis (PSNL) grants options and RSUs to Chief Legal Officer - Stock Titan
Personalis (PSNL) CEO receives major stock option and RSU grants - Stock Titan
Personalis (PSNL) awards RSUs and stock options to its CMO - Stock Titan
Investor Mood: Can Personalis Inc grow without external funding2026 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
Personalis promotes Richard Chen to president role - Investing.com
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):